252 related articles for article (PubMed ID: 17905619)
21. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
[TBL] [Abstract][Full Text] [Related]
22. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
23. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
24. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
[TBL] [Abstract][Full Text] [Related]
25. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats.
Ihaku D; Cameron L; Suzuki M; Molet S; Martin J; Hamid Q
J Allergy Clin Immunol; 1999 Dec; 104(6):1147-54. PubMed ID: 10588994
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Crimi N; Pagano C; Palermo F; Mastruzzo C; Prosperini G; Pistorio MP; Vancheri C
J Allergy Clin Immunol; 2003 Apr; 111(4):833-9. PubMed ID: 12704366
[TBL] [Abstract][Full Text] [Related]
28. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
31. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
32. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs.
Leick-Maldonado EA; Kay FU; Leonhardt MC; Kasahara DI; Prado CM; Fernandes FT; Martins MA; Tibério IF
Clin Exp Allergy; 2004 Jan; 34(1):145-52. PubMed ID: 14720275
[TBL] [Abstract][Full Text] [Related]
33. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
34. Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro.
Chue SC; Seow CJ; Duan W; Yeo KS; Koh AH; Wong WS
Int Immunopharmacol; 2004 Aug; 4(8):1089-98. PubMed ID: 15222984
[TBL] [Abstract][Full Text] [Related]
35. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
36. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
Meliton AY; Munoz NM; Leff AR
J Allergy Clin Immunol; 2007 Dec; 120(6):1316-23. PubMed ID: 17904626
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of NPC-17731 on BK-induced and antigen-induced airway reactions in guinea-pigs.
Ikemura T; Sasaki Y; Ohmori K
Clin Exp Allergy; 1998 May; 28(5):635-43. PubMed ID: 9645601
[TBL] [Abstract][Full Text] [Related]
38. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse.
Eum SY; Maghni K; Hamid Q; Campbell H; Eidelman DH; Martin JG
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):25-32. PubMed ID: 12495929
[TBL] [Abstract][Full Text] [Related]
40. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
